Skip to main content
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.
Serum neurofilament light chain reference database for individual application in paediatric care: a retrospective modelling and validation study.
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Myelin-oligodendrocyte glycoprotein antibody-associated disease.
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study.
Introducing the International Women in Multiple Sclerosis network.
Distinct representation of muscle weakness in QMG and MG-ADL - Authors' reply.